MENUNews Archive
Date: 04/22/2019
Gemcitabine, a front-line chemotherapy drug given to patients with pancreatic cancer, is made less effective because similar compounds released by tumor-associated immune cells block the drug’s action, research led by the University of Michigan Rogel Cancer Center found.
Date: 04/10/2019
Fewer than a quarter of breast cancer patients and a third of ovarian cancer patients diagnosed between 2013 and 2014 in two states underwent genetic testing for cancer-associated mutations, according to a study by researchers at the Stanford University School of Medicine and several other organizations.
Date: 04/04/2019
In a surprising finding, researchers at the Rogel Cancer Center showed the protein NLRP6 aggravated the difficult symptoms of gastrointestinal graft-vs.-host disease (GVHD). Knocking out this protein in mice led to significantly better survival and less severe GVHD.
Date: 03/21/2019
Not all cancer cells are created equal. Only a small number of cells in a patient’s initial tumor may have the power to travel through the blood, cross the protective membrane known as the blood-brain barrier, and directly attack the brain. But which cells? What makes them special? How can we target them? Which drugs are they vulnerable to? How likely is it that a patient’s initial tumor will metastasize to the brain?
Date: 03/21/2019
The foods that people in other countries put on their plates could teach Americans how to reduce their cancer risk. In a global tour under the Fulbright Global Scholar Award, Michigan Medicine cancer researcher Zora Djuric, Ph.D., is studying eating habits in Serbia, Guatemala and Australia.
Date: 03/18/2019
MRelay 2019, an annual fundraising event on the University of Michigan campus to support the American Cancer Society and its commitment to lifesaving research, treatment and care of cancer patients, is April 6!
Date: 03/18/2019
Rogel Cancer Center Infusion Pharmacy Renovation begins March 18 and continues through Fall 2019. Renovations WILL NOT impact the Outpatient Pharmacy, and we will continue to offer infusion at the Rogel Cancer Center.
Date: 03/13/2019
Exposure to chemotherapy can create hazards for nurses, pharmacists as they deliver lifesaving care to patients, but use of protective devices remains low.
Date: 03/01/2019
Researchers from the University of Michigan Rogel Cancer Center will attend the American Association for Cancer Research (AACR) Annual Meeting from Friday, March 29 through Wednesday, April 4, 2019. Many of them plan to participate in poster sessions and oral presentations. Below is a schedule of who is presenting, when, where and on what topic.
Date: 02/14/2019
Researchers from the Rogel Cancer Center have found that a genetic mutation seen in about half of all brain tumors produces a response that prevents radiation treatment from working. Altering that response using FDA-approved drugs restores tumors’ sensitivity to radiation therapy, extending survival in mice.